Q2 2026 revenue surged 66% year-over-year to $15.7 million, with net earnings of $2.7 million and EPS of $0.12. Gross margin improved to 31%, and the order backlog remained near record highs, supporting a positive outlook.Original document: Biorem Inc. [BRM] Earnings Release — Jul. 28 2026This is a…
Q2 2026 revenue surged 66% year-over-year to $15.7 million, with net earnings of $2.7 million and EPS of $0.12. Gross margin improved to 31%, and the order backlog remained near record highs, supporting a positive outlook.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.